Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
25.01
-0.09 (-0.36%)
At close: Jul 11, 2025, 4:00 PM
24.96
-0.05 (-0.20%)
After-hours: Jul 11, 2025, 7:49 PM EDT
Nektar Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts that cover Nektar Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $81.67, which forecasts a 226.55% increase in the stock price over the next year. The lowest target is $30 and the highest is $120.
Price Target: $81.67 (+226.55%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nektar Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $60 → $85 | Strong Buy | Maintains | $60 → $85 | +239.86% | Jul 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6.5 → $120 | Strong Buy | Maintains | $6.5 → $120 | +379.81% | Jun 24, 2025 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $15 → $30 | Hold → Strong Buy | Upgrades | $15 → $30 | +19.95% | Apr 11, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $90 | Hold → Buy | Upgrades | $90 | +259.86% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $98 | Strong Buy | Reiterates | $98 | +289.84% | Mar 13, 2025 |
Financial Forecast
Revenue This Year
43.96M
from 98.43M
Decreased by -55.34%
Revenue Next Year
40.72M
from 43.96M
Decreased by -7.35%
EPS This Year
-11.94
from -8.68
EPS Next Year
-19.72
from -11.94
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 50.5M | 54.6M | 54.6M |
| Avg | 44.0M | 40.7M | 34.9M |
| Low | 39.2M | 23.5M | 7.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -48.7% | 24.2% | 34.1% |
| Avg | -55.3% | -7.4% | -14.3% |
| Low | -60.2% | -46.5% | -80.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -10.53 | -9.50 | -10.59 | |
| Avg | -11.94 | -19.72 | -14.12 | |
| Low | -14.40 | -66.64 | -23.97 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.